3D Medicines Co., Ltd.
http://www.3dmedcare.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 3D Medicines Co., Ltd.
Genmab Accelerates Priority Candidates, Ends Enapotamab Vedotin Development
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.
Asia Deal Watch: LianBio Partners With Pfizer In Greater China, Gets Financial Backing
Plus deals involving Takeda/OrigiMed, Amcure/Hinova, AUM/Newsoara, Taiho/Lung Therapeutics, 3D Medicines/Aravive, HitGen/Baiyunshan, Dong-A/Jiangsu Hengrui, and Crescita/Juyou.
Velano Vascular: Vascular Access Via Peripheral IV Catheters
Velano Vascular Inc. aims to spare hospitalized patients the pain of numerous needle blood draws. It is commercializing a single-use, disposable vascular-access device that resembles a syringe and interacts with an existing peripheral intravenous catheter that has already been inserted in the patient’s hand or arm.
Velano Vascular Inc.
Velano Vascular Inc. aims to spare hospitalized patients the pain of numerous needle blood draws. It is commercializing a single-use, disposable vascular-access device that resembles a syringe and interacts with an existing peripheral intravenous catheter that has already been inserted in the patient’s hand or arm.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- 3DMed
- 3D Medicines (Sichuan) Co., Ltd.
- 3D Medicines (Beijing) Co., Ltd.